Research within the DDR brings together multidisciplinary concepts across pharmaceutics, chemistry, biomaterial technology and biological sciences in addressing difficult questions within the realm of ‘improved therapeutic bioavailability’ using the state-of-the art instrumentation. Our ultimate goal is in the successful deployment of therapeutic agents in a controlled and targeted manner using a variety of approaches including (1) nano- and micro- particulate drug delivery technologies (2) transdermal drug delivery and (3) rectal drug delivery. The group also explores biosensors and markers using nanotechnology.
It is our mission to improve pharmacotherapy through development of novel drug delivery systems and technologies. Our interests spun from establishing key concepts related the properties of the API, through to formulation and disposition of the active.
Augmented approach in the oral delivery of curcumin nanoparticles to the colon in colorectal cancer
Development of glucose-mediated insulin release nanoparticulate delivery systems
Oral delivery of poorly soluble drugs ( e.g. amphotericin B) via nanoparticulate technology
Polymeric protein-loaded microsphere delivery system for use in bone tissue engineering
Fluorogenic nanoclusters based-assay for telomerase detection
Cysteamine-gold nanoparticles: colorimetric probes with tunable dynamic range
Transdermal delivery of bioactive compounds
Browser does not support script.
Department for Pure and Applied Chemistry, University of Strathclyde, UK
St George’s London, UK
University of Nottingham Malaysia Jalan Broga, 43500 Semenyih Selangor Darul EhsanMalaysia
telephone: +6 (03) 8924 8034 email: rke.hub@nottingham.edu.my